AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.8000
+0.1108 (16.08%)
At close: Aug 13, 2025, 4:00 PM
0.7758
-0.0242 (-3.03%)
Pre-market: Aug 14, 2025, 8:53 AM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $9.04 million as of August 14, 2025. Its market cap has decreased by -91.30% in one year.
Market Cap
9.04M
Enterprise Value
16.80M
1-Year Change
-91.30%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $9.04M, a decrease of -85.79%. That is a compound annual growth rate of -36.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 9.04M | -58.10% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |